Simplex Trading’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $719K | Buy |
+44,300
| New | +$784K | ﹤0.01% | 2847 |
|
|
2025
Q4 | – | Sell |
-27,400
| Closed | -$400K | – | 10035 |
|
|
2025
Q3 | $400K | Buy |
27,400
+13,000
| +90% | +$164K | ﹤0.01% | 4111 |
|
|
2025
Q2 | $158K | Buy |
14,400
+14,000
| +3,500% | +$136K | ﹤0.01% | 4761 |
|
|
2025
Q1 | $3K | Buy |
+400
| New | +$3.72K | ﹤0.01% | 7887 |
|
|
2024
Q4 | – | Sell |
-900
| Closed | -$7K | – | 9602 |
|
|
2024
Q3 | $7K | Sell |
900
-600
| -40% | -$5.2K | ﹤0.01% | 7462 |
|
|
2024
Q2 | $12K | Buy |
1,500
+1,300
| +650% | +$11.7K | ﹤0.01% | 7326 |
|
|
2024
Q1 | $1K | Buy |
+200
| New | +$1.85K | ﹤0.01% | 8648 |
|
|
2023
Q3 | – | Sell |
-900
| Closed | -$9K | – | 9798 |
|
|
2023
Q2 | $9K | Sell |
900
-5,300
| -85% | -$58.5K | ﹤0.01% | 7523 |
|
|
2023
Q1 | $67K | Sell |
6,200
-7,500
| -55% | -$79.3K | ﹤0.01% | 5597 |
|
|
2022
Q4 | $153K | Sell |
13,700
-72,200
| -84% | -$759K | ﹤0.01% | 4560 |
|
|
2022
Q3 | $871K | Buy |
85,900
+79,800
| +1,308% | +$748K | ﹤0.01% | 2813 |
|
|
2022
Q2 | $55K | Sell |
6,100
-27,400
| -82% | -$252K | ﹤0.01% | 6374 |
|
|
2022
Q1 | $320K | Buy |
33,500
+33,300
| +16,650% | +$326K | ﹤0.01% | 4455 |
|
|
2021
Q4 | $2K | Sell |
200
-2,000
| -91% | -$17.4K | ﹤0.01% | 10065 |
|
|
2021
Q3 | $31K | Hold |
2,200
| – | – | ﹤0.01% | 8067 |
|
|
2021
Q2 | $31K | Buy |
2,200
+2,171
| +7,486% | +$40.8K | ﹤0.01% | 8207 |
|
|
2021
Q1 | $59K | Buy |
29
+28
| +2,800% | +$532 | ﹤0.01% | 6409 |
|
|
2020
Q4 | $1K | Sell |
1
-1
| -50% | -$18 | ﹤0.01% | 8159 |
|
|
2020
Q3 | $2K | Sell |
2
-3
| -60% | -$56 | ﹤0.01% | 7462 |
|
|
2020
Q2 | $10K | Buy |
+5
| New | +$128 | ﹤0.01% | 6668 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$23K | – | 8253 |
|
|
2019
Q4 | $23K | Buy |
+9
| New | +$175 | ﹤0.01% | 5852 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$3K | – | 7794 |
|
|
2018
Q3 | $3K | Buy |
+1
| New | +$27 | ﹤0.01% | 6988 |
|
|
2018
Q1 | – | Sell |
-12
| Closed | -$4K | – | 6851 |
|
|
2017
Q4 | $4K | Sell |
12
-23
| -66% | -$681 | ﹤0.01% | 4745 |
|
|
2017
Q3 | $17K | Buy |
+35
| New | +$1.15K | ﹤0.01% | 3313 |
|
|
2017
Q1 | – | Sell |
-20
| Closed | -$7K | – | 6761 |
|
|
2016
Q4 | $7K | Buy |
+20
| New | +$620 | ﹤0.01% | 4087 |
|
|
2016
Q2 | – | Sell |
-9
| Closed | -$1K | – | 6430 |
|
|
2016
Q1 | $1K | Buy |
+9
| New | +$147 | ﹤0.01% | 5239 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
Simplex Trading's TBPH Position: Q3 2025 in Review
Simplex Trading sold out of Theravance Biopharma (TBPH) in Q3 2025, closing a stake of 697 shares — an estimated $8.81K sold.
Simplex Trading first reported a position in TBPH in Q1 2016 and held it in 25 quarters. The position peaked at $487K in Q3 2022. 162 funds tracked by Wall St. Rank hold TBPH as of Q3 2025.
- Simplex Trading reported no remaining Theravance Biopharma position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 697 Theravance Biopharma shares in Q3 2025, an estimated $8.81K.
- Simplex Trading first reported a position in Theravance Biopharma in Q1 2016 and held it in 25 quarters.
- Simplex Trading's Theravance Biopharma position peaked at $487K in Q3 2022.
- 162 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.